drugset / Trial / NCT00995800
Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
RandomizedCrossoverQuadruple-blindTreatment
Summary
This is a dose-response study to determine how various measurements of airway inflammation respond to high and low dose FlutiForm®, and compared to placebo.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone propionate | Other / unclassified | 50 ug | Inhaled |
| Comparator | Fluticasone propionate | Other / unclassified | 250 ug | Inhaled |
| Comparator | Formoterol | Other / unclassified | 5 ug | Inhaled |
| Comparator | Formoterol | Other / unclassified | 10 ug | Inhaled |